CMP: 175

Claris Lifesciences Ltd. manufactures sterile injectables. The Company offer injectables in various delivery systems, such as glass and plastic bottles, vials, ampules, pre-filled syringes and non-PVC and PVC bags.

Claris Lifesciences is a decent bet in mid-cap space trading at a P/E of less than 14. It runs at a debt of 411 Crores with 153 Crores cash in hand. Revenues have risen marginally from 628 Crores to 652 Crores in the last 3 years. Profits have dipped from 89 Crores to 70 Crores over the last 3 years. NPM has dipped from 14% to less than 11% over the last 3 years. It issued its IPO in late 2010, and there's not much of recent quarter financial info. Buy and hold for long term gains.